mail
Print view
 

Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health

Ozempic alone doesn’t promote sustainable weight management and often results in weight regain after discontinuation. If you want long-term success, you need assistance from the digital health arsenal.

 

Weight loss injections are now widely used as miracle drugs for effortless skinniness. But without digital health, they just won’t work in the long run. The U.S. Food and Drug Administration, the FDA, approved Wegovy, a semaglutide injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition for use in addition to a reduced calorie diet and increased physical activity in 2021. 

Semaglutide was originally used for the treatment of type 2 diabetes, and was found to have a major lucky side effect: being very effective in assisting weight loss. Semaglutide injections are sold under different brand names: Ozempic and Rybelsus are supposed to be prescribed to diabetes patients, while Wegovy was specifically developed for treating obesity. 

These drugs belong to the group of GLP-1 receptor agonists, a category everybody just calls weight loss injections.

The miracle-drug epidemic

In the past few years, Ozempic (and the rest) has become a household name for the wealthy families of the most developed countries. It is best known as the miracle drug that makes you skinny without any effort, something that you can easily lay your hands on if you are ok with paying the $1000+ monthly price of moderate appetite. Regardless of whether you are supposed to get the injections from the medical point of view.

How come these drugs became a magic injection epidemic marketed by 19-year-old influencers on TikTok and A-list Hollywood celebrities? Legends from Oprah Winfrey to Whoopi Goldberg, from Al Roker to Elon Musk have an opinion on the issue, and it’s almost impossible to keep track of the dozens (or hundreds) who openly speak about using Ozempic to lose or manage weight. 

The issue is a trending topic on all platforms, the #ozempic hashtag has well over a billion views on TikTok, where GLP-1 influencers share their experiences with the audience. They have tens or hundreds of thousands of followers, and they don’t rush to disclose what kinds of sponsorships are behind their weight loss content and often fail to mention potential side effects.

But the hype is not only visible on individual levels. In March 2023, WeightWatchers acquired the telehealth company Sequence. Soon after the company also launched WeightWatchers Clinic, a platform where clients – who qualify – get prescription weight loss medication. Quite an addition to WW’s traditional focus on nutrition and exercise. 

Ozempic alone won’t be enough in the long run

However, if you are willing to see a little beyond the borders of fairyland, it is obvious that the miracle drug narrative should be taken with a grain of salt. Quite a few people talk about how stopping Ozempic makes you immediately gain back the lost weight, including Dr. Terry Dubrow or Remi Bader. Not to mention others who openly discuss the uncomfortable side effects they experienced with these treatments, like Amy Schumer or Stephen Fry. 

“There are a million ways to lose weight, why not do it through something that isn’t as boring as working out? And the people who hate on it the most are the people who are secretly doing it or pissed off that they can’t afford it.” – said Kelly Osborne. And her statement is the best illustration of where the whole Ozempic/Wegovy hype went wrong. 

Read the whole article here.

Autor: Andrea Koncz
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Public Health Association (EUPHA)AGEM - Arbeitsgemeinschaft Ethnologie und MedizinHelix - Forschung & Beratung WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Gesellschaft für Public HealthCharité International AcademynewTreeCenter of Excellence